June 2023 DAIT Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

Note: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

June 2023 DAIDS Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

Note: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2024 Division of AIDS (DAIDS) Concept

Notice of Special Interest (NOSI)—Promoting Research and Development of Vaccines Against Enteric Viruses

The purpose of this Notice of Special Interest (NOSI) is to highlight NIAIDs interest in supporting vaccine research and development against enteric viruses. The scope of research supported is in three major topic areas: 1) address gaps in enteric virus research to support the development of a vaccine; 2) develop tools and resources to support vaccine development; and 3) develop and advance new vaccine candidates to prevent infection or severe gastrointestinal disease. This NOSI encourages studies focusing on rotavirus, caliciviruses, astroviruses, and adenoviruses (Types F, G).

Notice of Special Interest (NOSI)—Understanding Mucosal Immunity Against Enteric Eukaryotic Pathogens to Advance Discovery of New Interventions

The Notice of Special Interest (NOSI) invites applications to conduct research to better understand the basic biology and immunology associated with Cryptosporidium spp. (e.g., Cryptosporidium parvum and Cryptosporidium hominis), Giardia duodenalis (i.e., Giardia lamblia), and Entamoeba histolytica, including infection-induced mucosal immunity at the site of infection, leading to identification or discovery of new immune-mediated or host-directed interventions as countermeasures.

NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)

The NIAID New Innovator Award supports a postdoctoral and other candidates in non-independent positions or newly independent Early Stage Investigators of exceptional creativity who propose novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research of priority to NIAID. Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged.

T Cells Can Activate Themselves to Fight Tumors

AI Helps Create Better, Simpler Hepatitis, COVID-19 Tests

UAB Researchers Awarded $19.5 Million to Study Factors that Impact Sexual Health Among Women

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.uab.edu/news/health/item/13556-uab-researchers-awarded-19-5-million-to-study-hiv-acquisition-in-women
Research Institution
University of Alabama at Birmingham
Short Title
UAB Awarded $19.5 Million Study Factors Impact Sexual Health Among Women
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald

Secondary Bacterial Pneumonia Drove Many COVID-19 Deaths

Newly Discovered Immune System Mechanism Suppresses Parasitic Infection

Subscribe to